TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
SCLX

Scilex Holding Company

Healthcare · Drug Manufacturers - General

3.50$ -11.9% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Scilex Holding Company (SCLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 254 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SCLX
Line item Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – – 20 20 20 82 140 140 140 78 110 90 89 87 86 126 81 101 91 105 100 93 79 84 276 365 294 254
– – – – 5.6 5.6 5.6 22 0.7 0.5 0.2 23 56 31 31 30 31 69 25 47 38 50 40 42 29 34 16 38 42 36
– – – – 1.2 1.2 1.2 4.8 0.3 0.3 0.1 4.3 34 6.8 2.5 2.2 5.1 34 2.0 3.9 1.8 6.9 0.1 3.3 5.8 4.1 0.9 5.0 3.4 0.6
– – – – 1.2 1.2 1.2 4.8 0.3 0.3 0.1 4.3 34 6.8 2.5 2.2 5.1 34 2.0 3.9 1.8 6.9 – 3.3 5.8 4.1 0.9 – 3.4 0.6
– – – – 3.3 3.3 3.3 13 3.6 3.6 3.6 14 15 16 17 21 19 28 16 35 30 38 32 26 11 17 12 15 30 6.4
– – – – 0.3 0.3 0.3 1.1 0.6 0.6 0.6 2.6 1.9 1.2 0.9 1.4 2.3 3.1 3.9 4.2 3.5 3.1 2.4 2.4 3.0 2.5 1.1 4.8 4.5 4.2
– – – – – – – – – – – – 2.0 2.2 2.1 0.8 0.8 4.1 – – – – – – – – – – – –
– – – – 3.4 3.4 3.4 13 3.4 3.4 3.4 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13
– – – – 11 11 11 43 9.7 9.7 9.7 39 38 43 42 41 40 39 38 36 35 34 33 32 31 31 30 124 60 58
– – – – 56 56 56 223 8.8 8.9 10 302 342 342 318 50 75 116 243 274 281 319 312 286 290 333 456 577 548 564
– – – – 20 20 20 78 0.0 0.0 0.0 169 177 209 251 45 65 104 229 250 253 255 282 260 276 306 359 484 502 512
– – – – 7.2 7.2 7.2 29 14 14 14 58 57 58 48 0.7 10 35 116 109 94 76 – 36 40 41 55 – 88 83
– – – – 2.0 2.0 2.0 8.1 0.0 1.1 1.1 4.3 4.8 7.4 12 8.5 9.8 11 33 41 42 42 43 53 57 59 67 86 102 121
– – – – – – – – – – – 3.8 – – 6.2 – – – 6.9 17 16 29 14 0.8 – – – 22 – –
– – – – -35 -35 -35 -142 131 131 130 -224 -232 -252 -229 36 11 10 -163 -173 -190 -215 -211 -193 -211 -249 -177 -208 -249 -308
– – – – -66 -66 -66 -264 1.3 1.1 -9.8 -353 -362 -380 -358 -376 -407 -433 -469 -490 -515 -552 -557 -563 -589 -631 -889 -922 -965 -1,079
4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.9 4.9 4.4 4.4 4.0 4.0 3.8 3.8 4.0 4.1 4.0 3.9 3.6 3.4 3.8 7.0 6.9 6.9 6.9 7.0 6.9 6.9

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?